Immunisation and screening for cervical cancer is once again under the spotlight as the Ministry of Health and Prevention (MoHAP) recently launched a comprehensive national strategy to combat HPV ...

“Early screening is extremely important because cervical cancer is the second most common cancer among women in PNG, and it is preventable if detected early,” Dr. Bagita emphasized. Dr. Bagita ...

The claim is False. Pap smears help detect early signs of cervical cancer and are an important part of routine health checks. Though briefly uncomfortable for some, they do not cause any harm to the ...

HPV vaccination of boys, pap smear for women from age 25 also part of national strategy Cervical cancer, caused primarily by HPV, ranks as the fifth most common cancer among women in the UAE.

At-home self-sampling cervical screening looks likely to be an option in the future. But scientists warn that steps must be taken to ensure that the offer of at-home sampling doesn’t have a negative ...

Cervical cancer rates are on the rise among younger women, owing in part to a lack of awareness, screening and prevention. A new study found that the percentage of women screened for cervical ...

At-home cervical cancer tests could be rolled out next year to boost screening uptake Credit: Getty Planning is underway to allow women to order DIY tests through the NHS App - or potentially ...

DIY smear tests for women are part of an NHS plan to eradicate cervical cancer by 2040. Outgoing NHS boss Amanda Pritchard has unveiled measures to achieve the “world-leading ambition ...

Cervical cancer leads to approximately 685 deaths a year in England and most cervical cancer cases (99.8%) are caused by the human papillomavirus (HPV) virus. By increasing equitable uptake of both ...

NHS England previously outlined its ambition to eliminate cervical cancer by 2040, aligning with the World Health Organisation’s (WHO) global initiative to achieve a below 4 per 100,000 cervical ...

The G20 Health Working Group Summit, held in Durban, discussed several key issues including health finance and cervical cancer elimination, on Friday. The theme for this meeting was: Accelerate ...

Credit: aslysun/Shutterstock. Genmab has received approval from the Japan’s Ministry of Health, Labour and Welfare for Tivdak (tisotumab vedotin) to treat advanced or recurrent cervical cancer that ...